Related Experiment Videos
Postmenopausal tamoxifen treatment and endometrial pathology
I Cohen1, M M Altaras, J Shapira
1Department of Obstetrics and Gynecology, Sapir Medical Center, Kfar Saba, Israel.
Obstetrical & Gynecological Survey
|December 1, 1994
Abstract:
Tamoxifen is widely used as adjuvant therapy for postmenopausal breast cancer patients with positive estrogen receptors. Data on a possible association of endometrial pathologies with tamoxifen treatment have been accumulating. In this review, we examine the current literature and include our own experience with this occurrence. We recommend close supervision of these patients.